Vetenskapliga studier på mRNA

Temporal relation between second dose BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection

Cardiac

Læs mere

The clinical course of patients with previous acute and recurrent pericarditis receiving the BNT162b2 vaccine

Cardiac

Læs mere

The complexity of immunology, a rare adverse event following a Pfizer-BioNTech vaccine booster shot

Cardiac

Læs mere

The mRNA-Based Coronavirus Disease-2019 Vaccine-induced Severe Cardiomyopathy, A Rare Incident

Cardiac

Læs mere

The Novel Platform of mRNA COVID-19 Vaccines and Myocarditis, Clues into the Potential Underlying Mechanism

Cardiac

Læs mere

The Peripheral Immune Landscape in a Patient with Myocarditis after the Administration of BNT162b2 mRNA Vaccine

Cardiac

Læs mere

The Rise of mRNA COVID-19 Vaccine-Associated Myocarditis and Its Implications on the Future Use of This New Vaccine Platform

Cardiac

Læs mere

The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination

Cardiac

Læs mere

Torsades de Pointes Following Vaccination for COVID-19

Cardiac

Læs mere

Transient Myopericarditis Following Vaccination for COVID-19

Cardiac

Læs mere

Myocarditis should be consider in those with a troponin rise and unobstructed arteries following Pfizer vaccination

Cardiac

Læs mere

Myocarditis Temporally Associated With COVID-19 Vaccination

Cardiac

Læs mere

Myocarditis With COVID-19 mRNA Vaccines

Cardiac

Læs mere

Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination

Cardiac

Læs mere

Myocarditis, Pulmonary Hemorrhage, and Extensive Myositis with Rhabdomyolysis 12 Days After First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine, A Case Report

Cardiac

Læs mere

Myocarditis-induced Sudden Death after BNT162b2 mRNA COVID-19 Vaccination in Korea, Case Report Focusing on Histopathological Findings

Cardiac

Læs mere

Myokarditis nach mRNA-Impfung

Cardiac

Læs mere

Vetenskapliga studier på mRNA

Temporal relation between second dose BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection

Cardiac

The clinical course of patients with previous acute and recurrent pericarditis receiving the BNT162b2 vaccine

Cardiac

The complexity of immunology, a rare adverse event following a Pfizer-BioNTech vaccine booster shot

Cardiac

The mRNA-Based Coronavirus Disease-2019 Vaccine-induced Severe Cardiomyopathy, A Rare Incident

Cardiac

The Novel Platform of mRNA COVID-19 Vaccines and Myocarditis, Clues into the Potential Underlying Mechanism

Cardiac

The Peripheral Immune Landscape in a Patient with Myocarditis after the Administration of BNT162b2 mRNA Vaccine

Cardiac

The Rise of mRNA COVID-19 Vaccine-Associated Myocarditis and Its Implications on the Future Use of This New Vaccine Platform

Cardiac

The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination

Cardiac

Torsades de Pointes Following Vaccination for COVID-19

Cardiac

Transient Myopericarditis Following Vaccination for COVID-19

Cardiac

Myocarditis should be consider in those with a troponin rise and unobstructed arteries following Pfizer vaccination

Cardiac

Myocarditis Temporally Associated With COVID-19 Vaccination

Cardiac

Myocarditis With COVID-19 mRNA Vaccines

Cardiac

Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination

Cardiac

Myocarditis, Pulmonary Hemorrhage, and Extensive Myositis with Rhabdomyolysis 12 Days After First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine, A Case Report

Cardiac

Myocarditis-induced Sudden Death after BNT162b2 mRNA COVID-19 Vaccination in Korea, Case Report Focusing on Histopathological Findings

Cardiac

Myokarditis nach mRNA-Impfung

Cardiac

Myopericarditis after administration of the Comirnaty© vaccine against SARS-CoV-2

Cardiac

Myopericarditis After COVID-19 Booster Dose Vaccination

Cardiac

Myopericarditis After COVID-19 mRNA Vaccination

Cardiac